Compare PLSE & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | CINT |
|---|---|---|
| Founded | 2014 | 1995 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 458.2M |
| IPO Year | 2015 | 2021 |
| Metric | PLSE | CINT |
|---|---|---|
| Price | $52.69 | $3.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $22.00 | $7.35 |
| AVG Volume (30 Days) | ★ 583.6K | 89.3K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $840.00 | $16.69 |
| Revenue Next Year | $287.54 | $11.28 |
| P/E Ratio | ★ N/A | $17.94 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.56 | $2.80 |
| 52 Week High | $58.90 | $6.06 |
| Indicator | PLSE | CINT |
|---|---|---|
| Relative Strength Index (RSI) | 58.24 | 41.08 |
| Support Level | $15.64 | $2.80 |
| Resistance Level | $58.90 | $3.62 |
| Average True Range (ATR) | 4.28 | 0.18 |
| MACD | -0.56 | -0.02 |
| Stochastic Oscillator | 48.79 | 34.71 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
CI&T Inc operates as a partner in tech-integrated business solutions, helping organizations address complex challenges by integrating business approach, technology, and artificial intelligence into a single, coherent operating model. It is mainly engaged in the development of customizable software through the implementation of software solutions, including machine learning, artificial intelligence, data analytics, cloud migration and mobility technologies. The company provides technology services to various industry verticals, including Financial Services, Consumer Goods, Technology and Communications, Retail and Industrial Goods, Life Sciences, among others. The majority of the revenue is derived from providing technology services. Geographically, maximum revenue is derived from Brazil.